EA200600012A1 - Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку - Google Patents

Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку

Info

Publication number
EA200600012A1
EA200600012A1 EA200600012A EA200600012A EA200600012A1 EA 200600012 A1 EA200600012 A1 EA 200600012A1 EA 200600012 A EA200600012 A EA 200600012A EA 200600012 A EA200600012 A EA 200600012A EA 200600012 A1 EA200600012 A1 EA 200600012A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cancer
predisposition
ners1
heritage
polymorphism
Prior art date
Application number
EA200600012A
Other languages
English (en)
Other versions
EA011608B1 (ru
Inventor
Цезарий Цыбульский
Ян Любинский
Бохдан Горски
Бартломей Глиневич
Андржей Сикорский
Академя Медычна Поморска
Original Assignee
Цезарий Цыбульский
Ян Любинский
Горский, Бохдан
Бартломей Глиневич
Андржей Сикорский
Академя Медычна Поморска
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Цезарий Цыбульский, Ян Любинский, Горский, Бохдан, Бартломей Глиневич, Андржей Сикорский, Академя Медычна Поморска filed Critical Цезарий Цыбульский
Publication of EA200600012A1 publication Critical patent/EA200600012A1/ru
Publication of EA011608B1 publication Critical patent/EA011608B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Данное изобретение относится к способам и наборам для определения предрасположенности и к протоколам обследования развития рака, например рака простаты и/или молочной железы, основанных на наследственной мутации гена NBS1.
EA200600012A 2003-06-13 2004-06-14 Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку EA011608B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL360642A PL201608B1 (pl) 2003-06-13 2003-06-13 Sposób i zestaw do wykrywania wysokiej genetycznie uwarunkowanej predyspozycji do raka prostaty oraz zastosowanie zmiany germinalnej w obrębie genu NBS1
PCT/PL2004/000044 WO2004111272A2 (en) 2003-06-13 2004-06-14 Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer

Publications (2)

Publication Number Publication Date
EA200600012A1 true EA200600012A1 (ru) 2007-08-31
EA011608B1 EA011608B1 (ru) 2009-04-28

Family

ID=33550530

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600012A EA011608B1 (ru) 2003-06-13 2004-06-14 Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку

Country Status (4)

Country Link
EA (1) EA011608B1 (ru)
PL (1) PL201608B1 (ru)
UA (1) UA93344C2 (ru)
WO (1) WO2004111272A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
HUE058263T2 (hu) 2015-02-10 2022-07-28 Univ Hong Kong Chinese Mutációk detektálása rákszûrési és magzatelemzési célból
EP3967775B1 (en) 2015-07-23 2023-08-23 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free dna
TWI803477B (zh) 2017-01-25 2023-06-01 香港中文大學 使用核酸片段之診斷應用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055716A1 (en) * 1998-04-27 1999-11-04 Virginia Mason Research Center A gene associated with nijmegen breakage syndrome, its gene product and methods for their use

Also Published As

Publication number Publication date
PL201608B1 (pl) 2009-04-30
PL360642A1 (en) 2004-12-27
UA93344C2 (ru) 2011-02-10
WO2004111272A2 (en) 2004-12-23
WO2004111272A3 (en) 2005-06-09
EA011608B1 (ru) 2009-04-28

Similar Documents

Publication Publication Date Title
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
WO2007064776A3 (en) Markers for breast cancer
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
EA200971079A1 (ru) ГЕНЕТИЧЕСКИЕ ВАРИАНТЫ В Chr5p12 И 10q26 В КАЧЕСТВЕ МАРКЕРОВ ДЛЯ ПРИМЕНЕНИЯ ПРИ ОЦЕНКЕ РИСКА, ДИАГНОСТИРОВАНИИ, ПРОГНОЗИРОВАНИИ И ЛЕЧЕНИИ РАКА ГРУДИ
WO2004067570A3 (en) Prostate cancer diagnosis and treatment
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
DK1842226T3 (da) Homogen analytpåvisning
WO2006047484A3 (en) Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation
WO2005044990A3 (en) Use of differentially expressed nucleic acid sequences as biomarkers for cancer
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2005085863A3 (en) Biomarker: compound correlations in cancer diagnosis and therapy
MX2009001937A (es) Biomarcadores para el progreso de la enfermedad de alzheimer.
WO2005014846A3 (en) Methods for identifying risk of breast cancer and treatments thereof
DE60126248D1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
EP1987165A4 (en) Gene with influence on the human memory
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
WO2004110365A3 (en) Liver related disease compositions and methods

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU